Treatment of older patients with high-risk myelodysplastic syndromes (MDS): the emerging role of allogeneic hematopoietic stem cell transplantation (Allo HSCT).
about
The Blood and Marrow Transplant Clinical Trials Network: An Effective Infrastructure for Addressing Important Issues in Hematopoietic Cell TransplantationMyelodysplastic syndromes in the United States: an update for clinicians.Myelodysplastic Syndromes in the Elderly: Treatment Options and Personalized Management.Personalized treatment strategies for elderly patients with myelodysplastic syndromes.Increased expression of T cell immune response cDNA 7 in patients with acute graft-versus-host disease.
P2860
Treatment of older patients with high-risk myelodysplastic syndromes (MDS): the emerging role of allogeneic hematopoietic stem cell transplantation (Allo HSCT).
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Treatment of older patients wi ...... l transplantation (Allo HSCT).
@en
type
label
Treatment of older patients wi ...... l transplantation (Allo HSCT).
@en
prefLabel
Treatment of older patients wi ...... l transplantation (Allo HSCT).
@en
P2093
P2860
P1476
Treatment of older patients wi ...... l transplantation (Allo HSCT).
@en
P2093
Ehab Atallah
Jesse Troy
Kathryn Bylow
Wael Saber
P2860
P2888
P356
10.1007/S11899-013-0195-9
P577
2014-03-01T00:00:00Z
P6179
1029083388